Company Filing History:
Years Active: 2020
Title: The Innovative Contributions of Boris Shor
Introduction
Boris Shor is a notable inventor based in Cliffside Park, NJ (US). He has made significant contributions to the field of cancer treatment through his innovative work. His expertise and dedication have led to the development of a unique patent that addresses critical challenges in oncology.
Latest Patents
Boris Shor holds a patent for "Synergistic auristatin combinations." This invention relates to combinations of an auristatin or an auristatin-based antibody-drug-conjugate (ADC) with second active agents, including PI3K/mTOR inhibitors, MEK inhibitors, taxanes, or other anti-cancer agents. The methods described in this patent aim to treat abnormal cell growth by administering these combinations to patients. He has 1 patent to his name.
Career Highlights
Boris Shor is currently employed at Pfizer Corporation, a leading global biopharmaceutical company. His role at Pfizer allows him to work on cutting-edge research and development projects that aim to improve patient outcomes in cancer therapy. His contributions to the field have been recognized by his peers and the scientific community.
Collaborations
Boris collaborates with Puja Sapra, a fellow researcher at Pfizer. Together, they work on advancing the understanding and treatment of cancer through innovative approaches and therapies.
Conclusion
Boris Shor's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. His patent on synergistic auristatin combinations represents a significant step forward in the fight against cancer.